- Lower volatility than the market (beta 0.56)
- Established player in the Healthcare sector
- +12.6% YTD performance
Volatile ride for XTL Biopharmaceuticals Ltd. stock price on Monday moving between $2.36 and $2.82
(Updated on Jun 22, 2026)
The XTL Biopharmaceuticals Ltd. stock price gained 6.30% on the last trading day (Monday, 22nd Jun 2026), rising from $2.54 to $2.70. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 19.45% from a day low at $2.36 to a day high of $2.82. The price has risen in 8 of the last 10 days and is up by 31.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 16 thousand more shares were traded than the day before. In total, 26 thousand shares were bought and sold for approximately $71.26 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.40% during the next 3 months and, with a 90% probability hold a price between $1.94 and $3.63 at the end of this 3-month period.
XTLB Signals & Forecast
Mostly positive signals in the chart today. The XTL Biopharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.40 and $2.59. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 31.07%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). XTL Biopharmaceuticals Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock
XTL Biopharmaceuticals Ltd. finds support from accumulated volume at $2.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.459 between high and low, or 19.45%. For the last week, the stock has had daily average volatility of 9.65%.
Our recommended stop-loss: $2.60 (-3.78%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (XTLB) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect XTL Biopharmaceuticals Ltd. to open at $2.63, and during the day (based on 14 day Average True Range), to move between $2.59 and $2.81, which gives a possible trading interval of +/-$0.227 (+/-8.77%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 8.77% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.71 (0.37%) than the support at $2.67 (1.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is XTL Biopharmaceuticals Ltd. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
4.166
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2026 - $2.63 ( 2.73%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
XTLB Performance
Trading levels for XTLB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.09 | 14.28% |
| R2 | 2.91 | 7.78% |
| R1 | 2.80 | 3.77% |
| Price | 2.70 | |
| S1 | 2.45 | -9.22% |
| S2 | 2.34 | -13.24% |
| S3 | 2.17 | -19.73% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.25 | 20.37% |
| R2 | 2.85 | 5.56% |
| R1 | 2.71 | 0.370% |
| Price | 2.70 | |
| S1 | 2.67 | -1.11% |
| S2 | 2.61 | -3.33% |
| S3 | 2.38 | -11.85% |
FAQ
Click here for our free guide on how to buy XTL Biopharmaceuticals Ltd. Stock.
Buy XTLB